See also this year's filing and all EDGAR filings for this company.
PDF Report 0001335105_2019_Lixte_Biotechnology_Holdings_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001335105, Lixte Biotechnology Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,334,445 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 2,293 |
| 4 | LiabilitiesCurrent | 210,915 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,868,118 |
| 9 | ResearchAndDevelopmentExpense | -2,757 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,697 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,336,738 |
| 1 | Liabilities | 210,915 |
| 2 | Expenses | 1,865,361 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 4,125,823 |
| 5 | NetIncome | -1,861,664 |
| 6 | ComprehensiveNetIncome | -1,861,664 |
| 7 | BaseVar | 3,208,356 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.14 |
| 9 | EconomicCapitalRatio | 3.78 |
Edgar->Model Mapping
Feature Distribution
Change over Time
